278 related articles for article (PubMed ID: 2137512)
1. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone FR; Bevan MJ
J Exp Med; 1990 Feb; 171(2):377-87. PubMed ID: 2137512
[TBL] [Abstract][Full Text] [Related]
2. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines.
Nair S; Zhou X; Huang L; Rouse BT
J Immunol Methods; 1992 Aug; 152(2):237-43. PubMed ID: 1386866
[TBL] [Abstract][Full Text] [Related]
3. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
[TBL] [Abstract][Full Text] [Related]
4. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
Chen W; Carbone FR; McCluskey J
J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
[TBL] [Abstract][Full Text] [Related]
5. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
Rock KL; Rothstein L; Fleischacker C; Gamble S
J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
8. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
Rock KL; Gamble S; Rothstein L
Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
[TBL] [Abstract][Full Text] [Related]
9. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone FR; Bevan MJ
J Exp Med; 1989 Mar; 169(3):603-12. PubMed ID: 2784478
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
12. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
[TBL] [Abstract][Full Text] [Related]
14. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
[TBL] [Abstract][Full Text] [Related]
15. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.
Yeh KY; McAdam AJ; Pulaski BA; Shastri N; Frelinger JG; Lord EM
J Immunol; 1998 Jun; 160(12):5773-80. PubMed ID: 9637487
[TBL] [Abstract][Full Text] [Related]
16. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
Anjuère F; Horvath C; Cerottini JC; Luescher IF
Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
[TBL] [Abstract][Full Text] [Related]
17. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
19. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.
Norbury CC; Chambers BJ; Prescott AR; Ljunggren HG; Watts C
Eur J Immunol; 1997 Jan; 27(1):280-8. PubMed ID: 9022030
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.
Doe B; Selby M; Barnett S; Baenziger J; Walker CM
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8578-83. PubMed ID: 8710913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
